The projected fair value for Teads Holding is US$0.79 based on 2 Stage Free Cash Flow to Equity. Current share price of US$0.89 suggests Teads Holding is potentially ...

Sanofi and Regeneron’s Dupixent approved in Japan for children aged 6 to 11 years with bronchial asthma Approval based on global phase 3 program in children demonstrating Dupixent significantly ...

The deal for Intersect, a data center and energy developer, is set to help Google build out its infrastructure for artificial ...

NotebookLM’s new Data Tables feature automatically organizes information from your sources into structured tables that can be ...

Explore Excel’s latest new features such as Translate and the Formula-by-Examples tool, so multilingual reports update automatically and save ...